Midtown biotech raises $250M to bring lung cancer therapy to market

9 months ago 51

Nuvation Bio’s novel lung cancer drug, taletrectinib, is currently being reviewed by the U.S. Food and Drug Administration.

1. Homepage
2. Lung Cancer
3. Midtown biotech raises $250M to bring lung cancer therapy to market